Navigation Links
Long-Term Estrogen Therapy Does Up Breast Cancer Risk: Study
Date:4/2/2012

By Denise Mann
HealthDay Reporter

SUNDAY, April 1 (HealthDay News) -- Several weeks after a study suggested that women who take estrogen-only hormone replacement to treat menopause symptoms may be at lower risk for developing breast cancer, another, much-larger study finds that when used for longer than 10 years, estrogen-only regimens actually raise a woman's long-term risk for breast cancer.

The new study was funded by the National Cancer Institute, part of the U.S. National Institutes of Health, whereas the previous one was partially funded by drug manufacturer Wyeth.

Researchers evaluated follow-up data from the Nurse's Health Study collected from 1980 through 2008. The women in the study were 30 to 55 years old in 1976. Overall, the risk for breast cancer was 88 percent higher among women who had taken estrogen plus progesterone for 10 to 14.9 years, compared to women who did not. This risk more than doubled for women who used estrogen-plus-progesterone therapy for 15 to 19.9 years.

Women who used estrogen-only therapy after menopause had 22 percent increased risk for breast cancer if they used it for 10 to 14.9 years, and 43 percent greater risk if they used it longer than 15 years.

There was no increased risk seen among women who took estrogen for fewer than 10 years. Women did not have an increased risk of dying from breast cancer, the study showed.

Hormone replacement therapy (HRT) fell from grace after the U.S. Women's Health Initiative study was stopped early in 2002 because HRT was shown to increase the risk of strokes and breast and ovarian cancer. Some subtleties have emerged since that time. For example, short-term use of HRT is now deemed fairly safe for some women who have severe menopausal symptoms. Estrogen-only therapy is reserved for women who have had a hysterectomy; women with an intact uterus who use HRT must take the hormone progestin (synthetic progesterone) with estrog
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. U.S. Underestimates Long-Term Costs of Obesity, Experts Say
2. Groundbreaking, long-term study of head injuries among athletes kicks off with NCAA grant
3. HIV/AIDS vaccine shows long-term protection against multiple exposures in non-human primates
4. First study on long-term cognitive effects of breast cancer chemotherapy finds subtle impairment among women who received CMF regimen
5. Study finds some insulin production in long-term Type 1 diabetes
6. People who retire early due to back problems face long-term financial disadvantage
7. Radiation plus chemotherapy provides long-term positive results for head and neck cancer patients
8. Oxford University Press and Medical Council on Alcohol announce long-term partnership
9. Severe Brain Injury When Young May Have Long-Term Effects
10. Emergency room visits risky for elderly residents from long-term care facilities
11. Nicotine Patches, Gums Wont Help Smokers Quit Long-Term: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Long-Term Estrogen Therapy Does Up Breast Cancer Risk: Study
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences ... sell Arterosil and Arterosil HP, and that all claims and counterclaims have been ... Sciences, LLC (VHS) in the United States District Court for the Southern District ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... The Kentucky ... workers are qualified for the position they are applying for, they are unable to ... many employers are considering altering drug testing policies in order to be able to ...
(Date:8/28/2015)... , ... August 28, 2015 , ... As reported ... Merz, received FDA clearance for results that last for two years, the longest ... news for patients who are looking for a long-lasting, effective solution for their cellulite, ...
(Date:8/28/2015)... ... , ... “ Frequentz ” was featured on NewsWatch as part of its ... market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology ... to track product movement from beginning to end. , Businesses benefit greatly from having ...
(Date:8/28/2015)... Jordan, Utah (PRWEB) , ... August 28, 2015 ... ... been awarded a three-year accreditation for its adolescent residential, counseling, day treatment and ... demonstrates that it meets international standards for quality and its pursuit of excellence. ...
Breaking Medicine News(10 mins):Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2
... MedQuist Inc.,(Pink Sheets: MEDQ) announces that it ... Chain Systems, one of the nation,s largest ... and,allowing them to complete the MedQuist suite ... solutions. As partners, MedAssets and MedQuist ...
... 2 Filtrona Fibertec, a division of,Filtrona plc, ... fluid handling components, celebrated the completion,of the recent ... a Grand Opening,celebration. (Logo: http://www.newscom.com/cgi-bin/prnh/20061127/DCM011LOGO ... more than double the size of,production floor space ...
... Oct. 2 Abbott (NYSE: ABT ),announced today ... waived status under the Clinical Laboratory Improvement Amendements,of 1988 ... it,more widely available for use beyond the hospital setting. ... and accurate and,can be made more broadly available to ...
... California, October 2 joimax GmbH, Campbell,CA, is pleased ... Inc. the company is moving to larger premises in ... October 1st, 2007,joimax, Inc. will be located at ... CA 95008 USA "This move reflects the strong ...
... Genetic Engineering and,Biotechnology News, (GEN) first online video ... up by more than 180 media outlets since its,release ... to run on GEN,s,Biotech Video Channel, is a corporate ... the Multimedia News Release, go to:, http://www.prnewswire.com/mnr/gen/29564/ ...
... has added over,6,000 menu items from 70 of ... http://www.NutritionPedia.com, the only online nutrition,search engine. ... content of their favorite menu items available at ... style restaurants such as,Applebee,s Neighborhood Bar and Grill, ...
Cached Medicine News:Health News:MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions 2Health News:MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions 3Health News:Filtrona Fibertec Ningbo, China Plant Celebrates Expansion 2Health News:Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge 2Health News:Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge 3Health News:Video: GEN Video Hits Home with Web Audience 2Health News:NutritionPedia Adds Nutrition Facts for Over 6,000 Menu Items From 70 Leading Fast-Casual and Family Dining Restaurant Chains 2
(Date:8/28/2015)... 2015 Research and Markets ... "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... ranibizumab was approved by CFDA to treat wet age- ... a product of Novartis, is available in the Chinese ... developed drug for the treatment of wet AMD in ...
(Date:8/28/2015)... Company plc ("Perrigo") (NYSE: PRGO ; TASE) today ... OTC brands from GSK in an all cash transaction ... demonstration of Perrigo,s unique ability to maximize brand value ... countries.  Perrigo Chairman, President and CEO ... to complete this transaction, which clearly demonstrates our ability ...
(Date:8/28/2015)... PUNE, India , August 28, 2015 ... Essential Oils), Livestock (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by ... , Asia-Pacific , and Rest of ... by MarketsandMarkets, The global market for Eubiotics was valued at ... USD 7.05 Billion by 2020, at a CAGR of 7.4% ...
Breaking Medicine Technology:Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5
... - Partnership aims to provide convenient access to vaccination ... at work, - "Let,s Fight Flu Together!" initiative ... to 18 years old(1), - Campaign goal is ... for those vaccinated, CAMBRIDGE, Mass., Nov. 10 ...
... Well-Tolerated, Significantly Inhibited ... November 10 at 8:30 ... a.m. ET-, NEW ... a biotechnology company focused on,the development of compounds for the treatment of cardiovascular ...
Cached Medicine Technology:Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families 'Let's Fight Flu Together!' 2Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families 'Let's Fight Flu Together!' 3Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families 'Let's Fight Flu Together!' 4Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families 'Let's Fight Flu Together!' 5Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families 'Let's Fight Flu Together!' 6VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 2VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 3VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 4VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 5VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 6VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 7VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease 8
Inquire...
Inquire...
... and optical performance, the SZX7 is designed ... in every task, from routine preparations to ... the best zoom ratios in its class ... color and accurate reproduction of the original ...
... The series SV stereomicroscopes are ... Thanks to their mature modular ... the job in hand. This ... of demanding routine applications will ...
Medicine Products: